Futura Medical plc

Informe acción AIM:FUM

Capitalización de mercado: UK£111.5m

Futura Medical Dirección

Dirección controles de criterios 2/4

Futura Medical's CEO is James Barder, appointed in Jun 2001, has a tenure of 23.42 years. total yearly compensation is £469.55K, comprised of 59.1% salary and 40.9% bonuses, including company stock and options. directly owns 0.49% of the company’s shares, worth £542.42K. The average tenure of the management team and the board of directors is 10.4 years and 3.1 years respectively.

Información clave

James Barder

Chief Executive Officer (CEO)

UK£469.6k

Compensación total

Porcentaje del salario del CEO59.1%
Permanencia del CEO23.4yrs
Participación del CEO0.5%
Permanencia media de la dirección10.4yrs
Promedio de permanencia en la Junta Directiva3.1yrs

Actualizaciones recientes de la dirección

Recent updates

Need To Know: Analysts Are Much More Bullish On Futura Medical plc (LON:FUM)

Sep 13
Need To Know: Analysts Are Much More Bullish On Futura Medical plc (LON:FUM)

We Think Futura Medical (LON:FUM) Can Easily Afford To Drive Business Growth

Apr 17
We Think Futura Medical (LON:FUM) Can Easily Afford To Drive Business Growth

Here's Why We're Not At All Concerned With Futura Medical's (LON:FUM) Cash Burn Situation

Jan 05
Here's Why We're Not At All Concerned With Futura Medical's (LON:FUM) Cash Burn Situation

Is Futura Medical (LON:FUM) In A Good Position To Invest In Growth?

Jul 28
Is Futura Medical (LON:FUM) In A Good Position To Invest In Growth?

We Think Futura Medical (LON:FUM) Needs To Drive Business Growth Carefully

Mar 18
We Think Futura Medical (LON:FUM) Needs To Drive Business Growth Carefully

We're Keeping An Eye On Futura Medical's (LON:FUM) Cash Burn Rate

Sep 25
We're Keeping An Eye On Futura Medical's (LON:FUM) Cash Burn Rate

Here's Why We're Not Too Worried About Futura Medical's (LON:FUM) Cash Burn Situation

May 10
Here's Why We're Not Too Worried About Futura Medical's (LON:FUM) Cash Burn Situation

We're Interested To See How Futura Medical (LON:FUM) Uses Its Cash Hoard To Grow

Jan 10
We're Interested To See How Futura Medical (LON:FUM) Uses Its Cash Hoard To Grow

What We Learned About Futura Medical's (LON:FUM) CEO Compensation

Dec 21
What We Learned About Futura Medical's (LON:FUM) CEO Compensation

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de James Barder en comparación con los beneficios de Futura Medical?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2024n/an/a

-UK£4m

Mar 31 2024n/an/a

-UK£5m

Dec 31 2023UK£470kUK£277k

-UK£7m

Sep 30 2023n/an/a

-UK£6m

Jun 30 2023n/an/a

-UK£5m

Mar 31 2023n/an/a

-UK£5m

Dec 31 2022UK£435kUK£251k

-UK£6m

Sep 30 2022n/an/a

-UK£6m

Jun 30 2022n/an/a

-UK£6m

Mar 31 2022n/an/a

-UK£5m

Dec 31 2021UK£357kUK£243k

-UK£5m

Sep 30 2021n/an/a

-UK£4m

Jun 30 2021n/an/a

-UK£3m

Mar 31 2021n/an/a

-UK£3m

Dec 31 2020UK£309kUK£243k

-UK£2m

Sep 30 2020n/an/a

-UK£4m

Jun 30 2020n/an/a

-UK£6m

Mar 31 2020n/an/a

-UK£7m

Dec 31 2019UK£238kUK£236k

-UK£9m

Sep 30 2019n/an/a

-UK£9m

Jun 30 2019n/an/a

-UK£8m

Mar 31 2019n/an/a

-UK£7m

Dec 31 2018UK£276kUK£230k

-UK£6m

Sep 30 2018n/an/a

-UK£5m

Jun 30 2018n/an/a

-UK£4m

Mar 31 2018n/an/a

-UK£4m

Dec 31 2017UK£235kUK£230k

-UK£4m

Compensación vs. Mercado: James's total compensation ($USD609.37K) is above average for companies of similar size in the UK market ($USD369.71K).

Compensación vs. Ingresos: James's compensation has increased whilst the company is unprofitable.


CEO

James Barder (65 yo)

23.4yrs

Permanencia

UK£469,554

Compensación

Mr. James Henry Barder has been the Chief Executive Officer of Futura Medical PLC since April 2001. Mr. Barder was first involved with Futura Medical Plc as an investor in 1997. Previously, he served as Ma...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
James Barder
CEO & Executive Director23.4yrsUK£469.55k0.49%
£ 542.4k
Angela Hildreth
COO, Finance Director6.8yrsUK£374.79k0.047%
£ 52.7k
Kenneth James
Head of R&D & Executive Director8yrsUK£344.00k0.099%
£ 110.5k
William Potter
Chief Scientific Officer & Adviser to the Board12.8yrsUK£31.38ksin datos
Graham Smith
Head of Alliance Partnerships & Supplyno datasin datossin datos
Kevin Langridge
Head of Qualityno datasin datossin datos

10.4yrs

Permanencia media

68.5yo

Promedio de edad

Equipo directivo experimentado: FUM's management team is seasoned and experienced (10.4 years average tenure).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
James Barder
CEO & Executive Directorno dataUK£469.55k0.49%
£ 542.4k
Angela Hildreth
COO, Finance Director6.8yrsUK£374.79k0.047%
£ 52.7k
Kenneth James
Head of R&D & Executive Director8.6yrsUK£344.00k0.099%
£ 110.5k
Gordon Davis
Non-Executive Directorless than a yearsin datossin datos
Andrew Unitt
Senior Independent Non-Executive Director2.8yrsUK£52.00k0.013%
£ 14.2k
Jeffrey Needham
Independent Non-Executive Chairman3.1yrsUK£66.95k0.0092%
£ 10.3k

3.1yrs

Permanencia media

67.5yo

Promedio de edad

Junta con experiencia: FUM's board of directors are considered experienced (3.1 years average tenure).